Partners Stephen Forster, Alexander Hastings, Howard Young, and Jaqueline Berman authored an article for Law360 discussing key drug pricing programs and other areas to watch as the new Trump-Vance administration takes shape and members of the 119th US Congress prepare to take the oath.